Company: QTIWW
Filing Date: 2025-02-05
Form Type: 424B3
Source: 0001628280-25-004061
Chunk: 14

Company: QT IMAGING HOLDINGS, INC.
Filing Date: 2025-02-05
Form: 424B3
Chunk 14
---
”) with CMSC. The term of the Feasibility Study Agreement commenced on March 28, 2024 and remained in force until the end of December 2024. In connection with the Feasibility Study Agreement, CMSC initiated studies to evaluate the business, technical, and clinical values of the QT Breast Scanner including product quality validation, development and manufacturing studies, clinical evaluation, regulatory investigation, and market validation. CMSC has no right to reverse engineer the QT Breast Scanner and may only modify and disassemble the QT Breast Scanner as necessary to conduct the Feasibility Study.

Under the terms of the Feasibility Study Agreement, we provided support for the Feasibility Study as agreed with CMSC from time to time during the term of the Feasibility Study Agreement and used our commercially reasonable efforts to facilitate the Feasibility Study.

All know-how and intellectual property embodied in QT Breast Scanner are owned by us and all rights not expressly granted by us are reserved.

Yorkville Financing—Standby Equity Purchase Agreement and Yorkville Note

On November 16, 2023, GigCapital5, QT Imaging and Yorkville entered into the Standby Equity Purchase Agreement (the “

#### SEPA
”). Following the closing of the Business Combination, the Company has the right, provided there is no balance outstanding under the Yorkville Note (as defined below) or, if there is a balance outstanding under a Yorkville Note, with Yorkville’s prior written consent, or upon the occurrence of certain Trigger Events (as defined in the SEPA), to issue and sell to Yorkville, and Yorkville shall purchase from the Company, up to $50 million in aggregate gross purchase price (the “

#### Commitment Amount
”) of newly issued shares of the Common Stock (each such sale, an “

#### Advance
”) by delivering written notice to Yorkville (each, an “

#### Advance Notice
” and the date on which the Company is deemed to have delivered an Advance Notice, the “

#### Advance Notice Date
”). The Common Stock purchased pursuant to an Advance Notice will be purchased at a price equal to 97% of the lowest daily VWAP of the Common Stock during the three consecutive trading days commencing on the Advance Notice

<div align='center'>8</div>

#### Table of Contents
Date. “

#### VWAP
” for purposes of the SEPA means, for any trading day, the daily volume weighted average price of the Common Stock for such trading day on the Nasdaq Stock